Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for pain after ureteroscopy with stent placement
NCT03927781Phase 3Completed
- Sponsor
- University of Missouri
- Start
- Apr 2019
- Primary completion
- Oct 2019
- Countries
- 1
01
Overview
Phase 3, open-label trial of pregabalin in postoperative pain and ureteral stent-related symptoms (USRS), sponsored by University of Missouri. Primary endpoints: Number of Participants With One or More Adverse Events Related to Study Drug and Number of Participants Who Were Administered the Study Drug Correctly. Started Apr 2019; status: completed.
02
Drugs
pregabalin
03
Conditions
postoperative painureteral stent-related symptoms (USRS)
Beyond the preview
Go deeper on NCT03927781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03927781.